end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecuritiesDebtSecurities,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,ComprehensiveIncomeNetOfTax,DeferredCosts,DeferredRevenueCurrent,DeferredRevenueNoncurrent,Depreciation,DepreciationDepletionAndAmortization,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueLiabilitiesLevel1ToLevel2TransfersAmount,FairValueLiabilitiesLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,FinanceLeaseRightOfUseAsset,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncrementalCommonSharesAttributableToCallOptionsAndWarrants,InvestmentIncomeNet,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermInvestments,MarketableSecuritiesUnrealizedGainLoss,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesNoncurrent,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockSharesAuthorized,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensation,ShortTermInvestments,StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants,StockholdersEquity,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,SubleaseIncome,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation,WeightedAverageNumberOfSharesOutstandingBasic
2020-12-31,2021-03-31,10-K,"Bolt Biotherapeutics, Inc.",BOLT,CIK0001641281,USD,1598000.0,,1239000.0,,3452000.0,,,,46542000.0,25361000.0,1000.0,1000.0,17296000.0,17296000.0,,5542000.0,,7107000.0,,,1e-05,198000000.0,2130139.0,2130139.0,,2357000.0,1502000.0,,,,,2885000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34000.0,,,,,,,,,,,,,,,46193000.0,46542000.0,11264000.0,,,,,,,,,,,,1501000.0,9376000.0,,12267000.0,,0.095,579000.0,875000.0,,329000.0,,,,2523000.0,,,,,,5322000.0,4083000.0,,,1565000.0,-108399000.0,,,,17296000.0,,-104947000.0,,,,,,105296000.0,1e-05,20843367.0,15232275.0,15232275.0,,,
2021-03-31,2021-05-13,10-Q,"Bolt Biotherapeutics, Inc.",BOLT,CIK0001641281,USD,2888000.0,,1507000.0,-64000.0,436165000.0,2109000.0,2109000.0,5046340.0,324637000.0,271210000.0,1000.0,64000.0,207487000.0,207424000.0,37000.0,95481000.0,97046000.0,97046000.0,89939000.0,,1e-05,200000000.0,36331846.0,36331846.0,-24518000.0,,1502000.0,,300000.0,272000.0,-1.14,1658000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,4299000.0,-88000.0,,2000.0,1351000.0,36087.0,56000.0,15063000.0,2701000.0,1685000.0,2317000.0,2239000.0,1867000.0,4379000.0,21389000.0,324637000.0,12012000.0,36236000.0,64000.0,297019000.0,-190521000.0,-16559000.0,-24454000.0,-6028000.0,18426000.0,-18426000.0,664000.0,10684000.0,1628000.0,9056000.0,172000.0,11478000.0,,0.096,814000.0,208000.0,-64000.0,321000.0,198069000.0,58000.0,,4541000.0,244988000.0,129000.0,51902000.0,7606000.0,-24454000.0,5417000.0,3910000.0,14127000.0,1565000.0,1565000.0,-132853000.0,,,2109000.0,171188000.0,,303248000.0,188506000.0,,241959000.0,129000.0,771000.0,,,,,,21498306.0,44952.0,21507171.0
2021-06-30,2021-08-12,10-Q,"Bolt Biotherapeutics, Inc.",BOLT,CIK0001641281,USD,1614000.0,,1758000.0,-23000.0,452357000.0,2023000.0,2023000.0,5102618.0,347074000.0,248151000.0,19000.0,41000.0,252646000.0,252624000.0,,58302000.0,59867000.0,59867000.0,,,1e-05,200000000.0,37191005.0,37191005.0,-23544000.0,,4330000.0,8535000.0,200000.0,,-0.64,2414000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,4054000.0,,,,,,176000.0,40760000.0,4994000.0,4227000.0,4772000.0,4612000.0,2446000.0,15277000.0,51178000.0,347074000.0,19250000.0,65938000.0,,,,,-23585000.0,176000.0,23761000.0,-23761000.0,902000.0,25483000.0,2323000.0,23160000.0,,25977000.0,,0.108,1515000.0,867000.0,41000.0,233000.0,,,,3163000.0,,,,,,6309000.0,4551000.0,19707000.0,1565000.0,1565000.0,-156438000.0,0.0,,,186686000.0,,295896000.0,,420000.0,,23000.0,,,1e-05,10000000.0,0.0,0.0,36595112.0,22279.0,36617390.0
2021-09-30,2021-11-09,10-Q,"Bolt Biotherapeutics, Inc.",BOLT,CIK0001641281,USD,5155000.0,,2058000.0,-38000.0,454784000.0,2226000.0,2226000.0,5202241.0,333550000.0,222488000.0,11000.0,49000.0,266921000.0,266883000.0,,23649000.0,25214000.0,25214000.0,,,1e-05,200000000.0,37248072.0,37248072.0,-23410000.0,,5207000.0,12206000.0,300000.0,,-0.63,3945000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,4941000.0,,,,,,131000.0,39542000.0,4994000.0,4227000.0,4772000.0,4612000.0,1228000.0,14612000.0,58637000.0,333550000.0,23695000.0,77639000.0,,,,,-23395000.0,131000.0,24278000.0,-23526000.0,1229000.0,24930000.0,2411000.0,22519000.0,,25216000.0,,0.109,837000.0,990000.0,-15000.0,217000.0,,,,9595000.0,,,,,,7689000.0,5631000.0,19337000.0,1565000.0,1565000.0,-179833000.0,752000.0,,,189244000.0,,274913000.0,,,,185000.0,,,1e-05,10000000.0,0.0,0.0,37206793.0,7720.0,37214513.0
